Ann: Mayne Pharma to present at HC Wainwright conference in NY, page-9

I find presentation at this particular conference
concerning. Firstly What is the purpose ??
Surely an investor presentation to potential
investors in ASX would be more beneficial.
This company with its current range of products
can invest heavily ( business acumen aside ) to
gain market share. The overheads in Marketing
can be more than affordable thus showing bottom
line losses. In turn SP low as a reflection allowing
Equity or Hedge fund takeover. Obviously once
customer base established S and M can be substantially
reduced resulting in fantastic Net Profits. I just want
the Chairman and CEO reminded of who they are
by law required to work for.